Table 1.
Effect of probiotic supplementation on the health status of individuals with ASD.
Probiotics | Species | Dose and duration | Effects | References |
---|---|---|---|---|
L. plantarum WCSF1 | Children with ASD, 4–16 years old | 4.5 × 1010 CFU per capsule per day for 3 weeks during the 12 weeks study duration | Improve behavioral scores and the stool consistency, increase Enterococci and Lactobacilli group, decreased Clostridium cluster XIVa | Parracho et al. (2010) |
Any type of probiotic | Children with ASD, 2.5–18 years old | Daily usage (33%) | Lower levels of total SCFAs; Marginally elevate the level of Lactobacillus | Adams et al. (2011) |
L. acidophilus Rosell-11 | Autistic children, 4–10 years old | 5 × 109 CFU per gram twice a day for 2 months | Decrease D-arabinitol and D-arabinitol/L-arabinitol ration in urine | Kałużna-Czaplińska and Błaszczyk (2012) |
L. delbruecki, B. longum | 1010 CFU per capsule,3 times a day for 6 months | Decrease the ATEC score, improve speech/language communication, sociability, sensory cognitive awareness, and health/physical behavior | West et al. (2013) | |
3 Lactobacillus strains, 2 Bifidobacterium strains, and a Streptococcus strain (60:25:15 ratio) | Children with ASD, 2–9 years old | 3 capsules per day (1 capsule thrice a day) for 4 months | Normalize Bacteroidetes/Fircumutes ratio, increase Bifidobacterium, and reduce Desulfovibrio spp. and TNF-α level in feces | Tomova et al. (2015) |
L. delbrueckii subsp. Bulgaricus, L. acidophilus, B. breve, B. longum, B. infantis, L. paracasei, L. plantarum, S. thermophiles | Children with ASD, 12 years old | 5 months of treatment period (4 weeks of initial treatment +4 months of follow up treatment);10 months of follow up period | Improve autistic core symptoms and abdominal symptoms | Grossi et al. (2016) |
Saccharomyces boulardii | A 16-year-old boy with Autism | 3 × 109 CFU per capsule, initiated at 6 capsules daily (2 at breakfast, 2 at lunch, 1 at dinner, and 1 at bedtime), 12 capsules daily after 1 weeks, and 24 capsules after 3 months | Reduce obsessive compulsive disorder and self-injurious behavior | Kobliner et al. (2018) |
B. longum, L. rhamnosus, L. acidophilus | Autistic children, age from 5–9 years old | 1 × 108 CFU per gram, 5 g per day for 3 months | Decrease severity of the ASD and GI symptoms; Increase abundances of Bifidobacteria and Lactobacillus | Shaaban et al. (2018) |
L. rhamnosus, L. paracasei and B. longum | Autistic children aged between 9–12 years old | 2 × 1010 CFU, once daily for 6 weeks | Improve autistic symptoms (assessed by ATEC) | Tharawadeephimuk et al. (2019) |
6 bacteria (the strain was not shown) | Children with ASD, age from 3–8 years old | Each bacteria was 1 × 109 CFU/gram, 6 g per day, in combination with applied behavior analysis training for 4 weeks. | Alleviate the autism symptom (assessed by ATEC scores); Improve the GI symptom (assessed by a GI questionnaire) | Niu et al. (2019) |
S. thermophilus, B. breve, B. longum, B. infantis, L. acidophilus, L. plantarum, L. paracasei, L. delbrueckii subsp. bulgaricus | Children with ASD, age range from 18–72 months | 4.5 × 1011 bacteria each packet, 2 packets/day in the first month and 1packet/day in the following 5 months | Decline the ADOS scores in ASD children without GI symptoms; Improve GI symptoms, adaptive functioning, and sensory profiles in ASD children with GI symptoms; | Santocchi et al. (2020) |
L. plantarum PS128 | Autistic children and adolescents aged 45–127 months | 3 × 1010 CFUs and 6 × 1010 CFUs of the probiotic if children weight was less than 30 kg and a higher weight, respectively. | Improve the Clinical Global Impression (CGI) scores | Mensi et al. (2021) |
L. plantarum PS128 | Individuals with ASD aged 3–20 years | Combination therapy of daily 2 capsules (6 × 1010 CFUs) for 28 weeks and oxytocin starting on week 16 | Improve social and behavioral measurements, the ABC total score, ABC stereotyped behavior sub-score, and SRS cognition sub-score in a trend; Significantly improve Clinical Global Impression; enrich beneficial bacteria (Blautia, Barnesiella, ChristensenellaceaeR7, and Ruminococcaceae UCG-002) in the gut; decrease IL-1β in serum | Kong et al. (2021) |
S. thermophilus, B. breve, B. longum, B. infantis, L. acidophilus, L. plantarum, L. paracasei, and L. delbrueckii subsp. Bulgaricus | Children aged 18–72 months diagnosed with ASD | A commercial probiotics formulation (the number of bacteria was not shown) | Decrease the power in frontopolar regions in β and γ bands, increase coherence in the same bands, and shift the frontal asymmetry | Billeci et al. (2022) |
Bifidobacterium spp. and Lactobacillus spp. | Children with ASD aged 2–5 years | 108 bacteria/g, 10 grams daily for 3 months | Significantly increase Bifidobacterium spp. and Lactobacillus spp. in the stool; improve autism scale, sleep disturbances, communication to speak, social networking, and hyperactivity; reducing GI symptoms | Meguid et al. (2022) |